Is Core Laboratories NV (CLB) overvalued? · P/E 21, rev $526.5M
Core Laboratories NV (CLB) is a oil & gas equipment & services company listed on US.
This page asks whether Core Laboratories NV (CLB) looks expensive on cached numbers — not a short thesis.
Latest reported CLB revenue for 2025-12-31 was $526.5M. Net income was $29.7M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. CLB currently screens at market cap $596.0M and trailing P/E 21.2.
CLB currently screens at market cap $596.0M and trailing P/E 21.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CLB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CLB stock page for the full model, not this heading.
Not investment advice.